Stock overview
Resmed Inc (RMD)
$195.27+1.76%Aft $195.27 (+0.00%)Market cap $28.33B
Stock Scorer
Scoring…
Analyst consensus
$248.60
- Analysts15
- Implied upside+27.3%
- Target range$180.00 to $325.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Congress trades
| Date | Member | Action | Amount |
|---|---|---|---|
| 2026-03-27 | Alan Armstrong | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | July 9, 2026 | PRIMARY DOCUMENT |
| 8-K | July 7, 2026 | 8-K |
| 144 | July 7, 2026 | View on EDGAR |
| SCHEDULE 13G/A | July 1, 2026 | View on EDGAR |
| 4 | June 9, 2026 | PRIMARY DOCUMENT |
| 144 | June 8, 2026 | View on EDGAR |
| 4 | June 3, 2026 | PRIMARY DOCUMENT |
| 144 | May 27, 2026 | View on EDGAR |
Frequently asked questions
What do analysts expect for RMD?
15 analysts cover Resmed Inc (RMD). The consensus rating is Buy and the average price target is $248.60, in a range of $180.00 to $325.00.
Are insiders buying or selling RMD?
We have no qualifying Form 4 insider purchases or sales on record for Resmed Inc (RMD). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see RMD SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed July 9, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.